卢宾推出FDA批准的Xigduo XR药片用于糖尿病治疗. Lupin launched FDA-approved generic Xigduo XR tablets for diabetes treatment.

印度制药公司Lupin在美国获得FDA批准后,推出了糖尿病治疗药物达帕格利弗洛辛和甲胺延长释放片的通用版本. Indian pharmaceutical company Lupin has launched a generic version of the diabetes medication dapagliflozin and metformin hydrochloride extended-release tablets in the U.S. following FDA approval. 这种药物有四个强度,与品牌Xigduo XR生物等价,为患者提供一种潜在的更实惠的选择来治疗2型糖尿病. The drug, available in four strengths, is bioequivalent to the brand-name Xigduo XR, offering patients a potentially more affordable option for managing type 2 diabetes.